Research suggests that Manjistha (Rubia cordifolia) may offer properties relevant to acne management, including antimicrobial activity against acne-associated bacteria such as Cutibacterium acnes and Staphylococcus species, as well as anti-inflammatory and antioxidant effects identified in laboratory and animal studies. The available evidence comes primarily from in vitro assays, animal models, and formulation studies — including polyherbal capsule and gel preparations, a nanoparticle delivery system, and a 2026 narrative review — rather than from randomized controlled trials in human populations, which represents a significant limitation in drawing firm conclusions about clinical effectiveness. Studies indicate that Manjistha is frequently studied as one ingredient among several in combination formulations, making it difficult to isolate its individual contribution to observed effects. Overall, the body of evidence is preliminary and directionally supportive, but human clinical trials would be needed to substantiate these findings for practical use in acne treatment.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Unveiling the Modern Therapeutic Properties and Folk Medicinal Riches of Rubi... | Review | 2026 | Supports | 92 |
| Evaluation of Anti-inflammatory and Antimicrobial Activity of AHPL/AYCAP/0413... | Other | 2017 | Supports | 88 |
| Polyherbal Antiacne Gel: In Vitro Antibacterial Activity and Efficacy Evaluat... | Other | 2024 | Supports | 85 |
| ZnO Nanoparticles of Rubia cordifolia Extract Formulation Developed and Optim... | Other | 2022 | Supports | 72 |
| Unveiling the antimicrobial and antioxidant potential of natural products: in... | Other | 2025 | Supports | 62 |